CIK 0001701541 · Non-accelerated filer<br>Smaller reporting company
Black Diamond Therapeutics, Inc.
Sign in to watch- Ticker
- BDTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 814254660
- Phone
- 617-417-5868
- Business address
- 245 FIRST STREET, 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- Aset Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-13 | Yurasov Sergey CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2023-02-13 | Ni Fang SEE REMARKS | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2023-02-13 | Jones Erika SEE REMARKS | Grant or award | +5,075 | 10,150 | ||
| 2023-02-13 | Jones Erika SEE REMARKS | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2023-02-13 | Epstein David M. SEE REMARKS | Grant or award · Stock Option (Right to Buy) | +420,000 | 420,000 | ||
| 2023-02-13 | Buck Elizabeth CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2023-02-13 | Hatzis-Schoch Brent SEE REMARKS | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2022-12-22 | Ni Fang SEE REMARKS | Purchase | +36,363 | $1.28 | $47K | 125,389 |
| 2022-12-21 | Ni Fang SEE REMARKS | Purchase | +20,000 | $1.29 | $26K | 89,026 |
| 2022-12-16 | Velleca Mark A. Director | Grant or award | +8,424 | $1.50 | $13K | 21,157 |
| 2022-12-16 | DIXON WENDY L Director | Grant or award | +7,167 | $1.50 | $11K | 16,216 |
| 2022-12-16 | INGRAM ROBERT ALEXANDER FORMER DIRECTOR | Grant or award | +9,375 | $1.50 | $14K | 42,854 |
| 2022-12-16 | Behbahani Ali Director | Grant or award | +7,917 | $1.50 | $12K | 28,004 |
| 2022-10-31 | BIOTECH GROWTH N V 10% owner | Purchase | +99,801 | $2.25 | $225K | 5,377,839 |
Page 6 of 6 · 114 trades